Publications of Udo Reichl

Küchler, J., Opitz, P., Kupke, S. Y., Genzel, Y., Benndorf, D., & Reichl, U.Absolute quantification of influenza A virus proteins during single-round replication in vaccine producer cell linesPresented at: 16^th PEACe (Protein Expression in Animal Cells) ConferenceSitges (Spain), September 24, 2023.

Lemke, G., Zuniga-Banuelos, F. J., Grote, V., Hoffmann, M., Rapp, E., & Reichl, U.N-glycan Sulfation on Human IgA: In-Depth N-glycoproteomic Analyses of Sulfated N-glycan Site-Specificity and Distribution on Human IgA IsotypesPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Pelz, L., Dogra, T., Boehme, J. D., Hein, M. D., Marichal-Gallardo, P., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivoPresented at: Cell Culture Engineering (CCE) XVIII Cancun (Mexico), April 23, 2023.

Pelz, L., Dogra, T., Boehme, J. D., Marichal-Gallardo, P., Hein, M. D., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.A Scalable High-Yield Process for Production of Influenza A Virus Defective Interfering Particles and In Vivo StudiesPresented at: Himmelfahrtstagung on Bioprocess Engineering 2023Weimar (Germany), May 15, 2023.

Pelz, L., Dogra, T., Boehme, J. D., Marichal-Gallardo, P., Hein, M. D., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Influenza A Virus Chimeric OP7 Defective Interfering Particles: Cell Culture-based Production and In Vivo Antiviral EfficacyPresented at: 32^nd Annual Meeting of the Society for Virology (GFV)Ulm (Germany), March 25, 2023.

Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Reduced transcription of the mutated genomic segment 7 of the novel “OP7” influenza defective interfering particle intended for use as an antiviralPresented at: 8^th European Congress of VirologyGdańsk (Poland), May 4, 2023.

Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Promoter mutations in novel “OP7” influenza defective interfering particle severely reduce transcription of its genomic segment 7Presented at: 32^nd Annual Meeting of the Society for Virology (GfV)Ulm (Germany), March 28, 2023.

Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviralPresented at: 17^th Vaccine CongressGlasgow (Scotland), September 24, 2023.

Rexer, T., Alcalá Orozco, E. A., Hoang Son, T., Kleeberg, S., & Reichl, U.Platform for the scalable synthesis of human milk oligosaccharidesPresented at: The Origins and Benefits of Biologically Active Components in Human Milk ConferenceFlorida, USA, June 4, 2023.

Sultan Mohideen, M. A. H., Khesali Aghtaei, H., Reichl, U., & Benndorf, D.Development of a packed foam bed bioreactor for biological methanationPresented at: 6th International Conference on Monitoring and Control of Anaerobic Digestion ProcessesLeipzig, Germany, March 22, 2023.

Wenzel, L., Ruhnau, J., Hoffmann, M., Rexer, T., & Reichl, U.Synthesis of Synthetic Lipid-Linked Oligosaccharides for In-Vitro Glycoengineering of Hemagglutinin Peptides by a Cell-Free, Multi-Enzyme CascadePresented at: GlycoBioTec 2023Berlin, Germany, January 14, 2023.

Zuniga-Banuelos, F. J., Hoffmann, M., Budimir, I., Reichl, U., & Rapp, E.New avenues for human blood plasma biomarker discovery via improved in-depth analysis of the low-abundant N-GlycoproteomePresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Alcalá Orozco, E. A., Hoang Son, T., Rexer, T., & Reichl, U.In vitro multi-enzyme cascades for the synthesis of nucleotide sugarsPresented at: INTERfaces Conference on ‘Intensifying Biocatalytic Processes – From Enzyme and Material Design to Industrial Applications’ (IBPRO2022)Bielefeld, Germany, March 28, 2022.

Dogra, T., Pelz, L., Marc, H., Rüdiger, D., Boehme, J., Bruder, D., Kupke, S. Y., & Reichl, U.Reverse genetics for Influenza A virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccinationPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Göbel, S., Dorn, M., Jaén Chavez, K., Jordan, I., Sandig, V., Altomonte, J., Genzel, Y., & Reichl, U.Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processesPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.

Göbel, S., Jordan, I., Sandig, V., Altomonte, J., Genzel, Y., & Reichl, U.Towards the production of a fusogenic oncolytic rVSV-NDV virus in perfusion modePresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Göbel, S., Kortum, F., Jaén Chavez, K., Jordan, I., Sandig, V., Altomonte, J., Genzel, Y., & Reichl, U.Production of a fusogenic oncolytic VSV-NDV virus: cell-line screening and process development in small-scale suspension culturesPresented at: Advancing Manufacture of Cell and Gene Therapies VIICoronado, CA (USA), February 6, 2022.

Hein, M., Chawla, A., Arora , P., Cattaneo, M., Winkler, M., Pöhlmann, S., Genzel, Y., Kupke, S. Y., & Reichl, U.Production of influenza A virus-derived defective interfering particles for antiviral therapy in a high cell density perfusion cultivationPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Hellwig, P., Dittrich, A., Benndorf, D., & Reichl, U.Establishment of a click chemistry-based method for detection and characterizationof phage-host systems in anaerobic digestionPresented at: 2nd German Phage SymposiumStuttgart, Germany, May 23, 2022.

Hellwig, P., Heyer, R., Maus, I., Meinusch, N., Walke, D., Schlüter, A., Hassa, J., Sczyrba, A., Klocke, M., Mächtig, T., Schallert, K., Seick, I., Saake, G., Reichl, U., & Benndorf, D.Combined metagenomics and metaproteomics for analysis of the microbial community in a two-stage biogas plantPresented at: XIV Annual Congress of the European Proteomic AssociationLeipzig, Germany, April 3, 2022.